Thailand to Re-categorize Marijuana as Controlled Substance This Year

Regulations by 2FIRSTS.ai

May.21.2024

Thailand to Re-categorize Marijuana as Controlled Substance This Year

Thai Health Minister Somsak Thepsutin announced that marijuana will be reclassified as a Category 5 drug this year.

According to Asia News' report on May 21st, Thailand's Minister of Public Health, Somsak Thepsutin, announced on Monday (20th) that marijuana will be reclassified as a Schedule 5 controlled substance within this year.

A survey conducted by the National Institute of Development Administration (NIDA Poll) in Thailand showed that 60.38% of respondents "completely agree" with the reclassification of marijuana as a drug, 15.27% "somewhat agree," 14.5% "completely disagree," 8.93% "strongly disagree," and 0.92% did not comment. Additionally, 46.95% of respondents believe that the government should not compensate individuals affected by the reclassification, 35.03% believe compensation should be given to marijuana growers and businesses, and 10.08% believe compensation should only be given to growers. The survey included 1310 individuals aged 15 and older nationwide and was conducted on May 14th and 15th.

According to a NIDA poll, 68.93% of respondents have never used marijuana, while 31.07% have used it at some point.

References:

[1] More than 60% Thais support relisting marijuana as a drug: poll

Also Read:

[1] Changing Face of Thai Society: The Legalization of Marijuana

[2] Debate Over Legalization and Regulation of Cannabis in Thailand

#Traditional tobacco #Asia #Thailand #Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris Korea Extends IQOS ILUMA i Warranty to 18 Months, Says Move Will Boost Smoke-Free Product Growth

Philip Morris International’s Korea unit has extended the warranty for the “IQOS ILUMA i” heated tobacco series from 12 to 18 months, applying it retroactively to existing purchases, aiming to enhance user experience and market competitiveness.

Oct.15 by 2FIRSTS.ai

FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace

At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.

Oct.29 by 2FIRSTS.ai

SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores

According to an SKE release published on PR Newswire, the company is expanding its presence in the Korean market through convenience store and specialty retail channels. SKE has partnered with 7-Eleven Korea, placing its products in more than 5,700 stores nationwide, and is also working with OG9’s offline retail and B2B distribution network. On the product side, SKE is focusing on promoting the Crystal Bar TB1000 and Cloud Zero in Korea.

Nov.19 by 2FIRSTS.ai

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.